- 18 April, 2024
Geopolitics & National SecurityBharat Biotech
WHO’s supply suspension of Covaxin not to impact travel of people: MEA
New Delhi, Apr 7 (PTI) Days after the WHO suspended the supply of Covaxin through UN procurement agencies, India on Thursday said the move would not impact travel by people…
Covaxin to be evaluated as COVID-19 vaccine candidate in US as USFDA lifts clinical hold
New Delhi, Feb 19 (PTI). Bharat Biotech on Saturday said its Covaxin will be evaluated as a COVID-19 vaccine candidate in the US. In a statement, Ocugen Inc, Bharat Biotech's…
National Regulator approves “Conditional Market Authorization” of two COVID19 Vaccines- Covaxin and Covishield
The National Regulator, Drugs Controller General of India (DCGI), has given nod to market authorization of two COVID19 vaccines, Covaxin and Covishield subject to certain conditions, here today. The Subject…
WHO Approves Indian Covid 19 vaccine, Bharat Biotech’s COVAXIN for Emergency Use
Coming on the heels of PM Modi's aggressive vaccine diplomacy during the G20 summit and COP26 at Glasgow, WHO has granted emergency use listing (EUL) to COVAXIN® (developed by Bharat…
PM Modi thanks H. E. Scott Morrison for Australia’s recognition of India’s COVAXIN
The Prime Minister, Shri Narendra Modi has thanked the Prime Minister of Australia, H. E. Scott Morrison for Australia’s recognition of India's COVAXIN. In a tweet, the Prime Minister said;…
Facility augmentation of Bharat Biotech, 3 other PSEs being supported for augmented production of Covaxin
New Delhi [India], August 7 (ANI): The Union Ministry of Chemicals and Fertilizers on Friday informed that facility augmentation of Bharat Biotech and three other public sector enterprises (PSEs) are…
Covaxin receives certificate of Good Manufacturing Practice from Hungarian authorities
New Delhi [India], August 5 (ANI): Bharat Biotech manufactured COVID-19 vaccine Covaxin on Thursday received a certificate of Good Manufacturing Practice (GMP) compliance from the Hungarian authorities. "Another milestone in…
Bharat Biotech cancels contracts with 2 Brazil firms for Covaxin
New Delhi [India], July 23 (ANI): Bharat Biotech on Friday said it has terminated agreements it had signed with two Brazilian companies - Precisa Medicamentos and Envixia Pharmaceuticals LLC to…
Bharat Biotech dossier under review for Covaxin emergency use listing: WHO
New Delhi [India], July 19 (ANI): Officials of the World Health Organisation (WHO) had a meeting with those of Bharat Biotech and the Hyderabad-based vaccine maker's dossier for Emergency Use…
Bharat Biotech releases Phase 3 trial results of Covaxin, claims vaccine efficacy of 78.8 pc against COVID-19
Hyderabad (Telangana) [India], July 3 (ANI): Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 per…
Bharat Biotech to soon start Covaxin manufacturing facility in Bengaluru
New Delhi [India], June 30 (ANI): Hyderabad-based vaccine manufacturer Bharat Biotech on Wednesday said that the company hopes to start manufacturing its COVID-19 vaccine Covaxin in Bengaluru soon. "Bharat Biotech…
Bharat Biotech denies receiving advance payments, supplying vaccines to Brazil
Hyderabad (Telangana) [India], June 30 (ANI): Issuing clarification on COVAXIN pricing controversy in Brazil, Bharat Biotech on Tuesday said it followed a step-by-step regulatory approval process during the eight-month period,…
